Table 2.
No improvement (R2 = 0.06)* |
Nonresponse (R2 = 0.09) |
Nonpartial remission (R2 = 0.15)* |
Nonfull remission (R2 = 0.10) |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
β | OR† (95% CI)‡ | P | β | OR† (95% CI)‡ | P | β | OR† (95% CI)‡ | P | β | OR† (95% CI)‡ | P | |
Sertraline treatment | −0.24 | 0.79 (0.37–1.69) | 0.54 | 0.91 | 2.47 (1.39–4.41) | 0.002 | 1.03 | 2.80 (1.59–4.94) | <0.001 | 0.26 | 1.29 (0.77–2.18) | 0.33 |
Higher iBDI | 0.02 | 1.02 (0.98–1.06) | 0.32 | −0.01 | 1.00 (0.97–1.02) | 0.74 | 0.05 | 1.06 (1.03–1.09) | <0.001 | 0.06 | 1.06 (1.03–1.09) | <0.001 |
Family history of depression | −0.25 | 0.78 (0.40–1.51) | 0.46 | −0.13 | 0.88 (0.55–1.40) | 0.59 | 0.02 | 1.02 (0.64–1.63) | 0.93 | −0.12 | 0.89 (0.56–1.40) | 0.60 |
eDC | 1.01 | 2.75 (1.24–6.11) | 0.01 | 0.82 | 2.27 (1.37–3.76) | 0.001 | 0.71 | 2.04 (1.25–3.34) | 0.005 | 0.40 | 1.49 (0.93–2.38) | 0.10 |
Higher baseline A1C | 0.04 | 1.04 (0.90–1.20) | 0.61 | 0.01 | 1.01 (0.91–1.13) | 0.86 | −0.03 | 0.97 (0.87–1.08) | 0.55 | 0.02 | 1.02 (0.92–1.14) | 0.72 |
Younger age | 0.02 | 1.02 (0.99–1.06) | 0.19 | 0.03 | 1.03 (1.01–1.05) | 0.009 | 0.02 | 1.02 (1.00–1.04) | 0.06 | 0.02 | 1.02 (1.00–1.05) | 0.04 |
Non-Caucasian race | −0.30 | 0.74 (0.34–1.62) | 0.45 | 0.15 | 1.16 (0.68–1.97) | 0.59 | 0.05 | 1.05 (0.61–1.78) | 0.87 | 0.09 | 1.09 (0.65–1.83) | 0.73 |
Female sex | 0.05 | 1.06 (0.53–2.10) | 0.88 | 0.10 | 1.11 (0.68–1.80) | 0.68 | 0.11 | 1.12 (0.69–1.81) | 0.65 | 0.04 | 1.04 (0.66–1.66) | 0.86 |
*Nagelkerke R2 value.
†Coefficient for the constant.
‡OR/exponential β value (95% CI).